348 Industry Innovation – Mastitis therapy with immune cells by Mastivax

Click here for resource

348 Industry Innovation – Mastitis therapy with immune cells by Mastivax

In Significant Impact Groups:
AMU reduction strategies \
Species targeted: Dairy;
Age: Adult;
Summary:
Where to find the original material:
Country: NL
A new therapy for mastitis is being developed by Mastivax without the need of using antibiotics. Blood of an infected dairy cow is collected and the immune cells are isolated. The immune cells are then injected into the infected part of the udder. Under laboratory settings it has been demonstrated that the immune cells kill the bacteria causing mastitis. However this procedure needs further research to investigate effectiveness and treatment frequency.